Encens boswellia BS-85
Food supplement declared in France, declaration No 2023-5-452, decision dated 10 May 2023
Encens boswellia BS-85 (Biotikon) is a food supplement declared in France. Status: declared in France, may be marketed. None of the rules we check flags an issue with its declared composition.
- Brand
- Biotikon
- Food business operator placing the product on the market
- Biotikon
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Capsule
- Daily dose
- 1
- Not recommended (according to the manufacturer)
- Breastfeeding women, Children (under 12), Young children (aged 1 to 3), Pregnant women, Infants (under 1 year), Children (under 6), Children (under 10)
- Flavourings
- neutre
Declaration 194130, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Boswellia serrata Roxb. ex Colebr. | Résine | Poudre (de plantes séchées ou broyées) | 400 g |
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
Indications importantes : la dose journalière conseillée ne doit pas être dépassée. Les compléments alimentaires ne remplacent pas une alimentation équilibrée et variée, ni un mode de vie sain. Pour les enfants, les femmes enceintes et les mères allaitantes, il faut demander conseil à un médecin avant d’en consommer. Ne pas laisser à la portée des enfants.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Brand : Biotikon
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.